Skip to main content

Table 1 characteristic of patients

From: Cardiovascular risk knowledge in patients of South Asian origin living with rheumatoid arthritis: data from India and the UK

  Indian UK P value
Number 118 118  
Age (years); mean (SD) 44 (12) 45 (12) 0.545a
Female 83.9% 84.7% 1.000b
Highest level of education    0.870c
 1. None 11.0% 5.9%  
 2. GCSE/0 level/10th grade 17.8% 26.3%  
 3. A-level diploma vocational qualification/12th grade 18.6% 21.2%  
 4. Degree 20.3% 12.7%  
 5. post graduate 32.2% 33.9%  
Employment    0.971b
 Full time 18.6% 16.9%  
 Part time 5.9% 8.5%  
 Unemployment 3.4% 2.5%  
 Not working due to RA 0.8% 0.0%  
 Retired 5.9% 5.9%  
 Home maker 61.0% 61.0%  
 Student 4.2% 5.1%  
Age at diagnosis (years); mean (SD) 37 (11) 38 (11) 0.532a
Height (metres); mean (SD) 1.56 (0.08) 1.57 (0.09) 0.445a
Weight (kilograms); mean (SD) 57.9 (10.2) 57.4 (9.6) 0.675a
History of co-morbidities
 Heart attack 1.7% 0.8% 0.619b
 Angina 1.9% 5.9% 0.179b
 Diabetes 7.1% 11.9% 0.265b
 High blood pressure 25.0% 28.0% 0.658b
 High cholesterol 8.6% 16.1% 0.107b
 Obesity 19.5% 13.6% 0.287b
 Smoking 2.5% 8.5% 0.083b
 Previous smoking status 6.8% 7.6% 1.000b
 Family history of CVD 22.9% 20.3% 0.752b
 Information on TV or media 36.4% 33.1% 0.682b
CVD and diabetes medications
 Cholesterol lowering medications 5.5% 13.6% 0.045b *
 Blood pressure lowering medications 14.2% 25.4% 0.034b *
 Blood pressure of above patients    
  Normal 13% 50% 0.017c *
  Elevated 6% 0%  
  Stage 1 44% 43%  
  Stage 2 25% 7%  
  Not available 13% 0%  
 Insulin 4.5% 2.5% 0.490b
 Anti-inflammatory drugs 60.6% 53.8% 0.347b
 Corticosteroids 35.4% 25.4% 0.134b
 Disease-modifying antirheumatic drugs 100% 100% 1.000b
 Biological drugs 0% 12.7% < 0.001b *
 DAS 28 mean;(SD) 3.1(0.7) 4.0(0.8) < 0.001a *
 Disease duration (years); geometric mean 5.5 4.1 0.012a *
  1. * = significant at < 0.05 a = t test (for disease duration data were log transformed), b = Fisher’s exact test, c = Kendall’s tau-b